Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma

被引:5
作者
Kazuto Fukuda
Sachiyo Kogita
Yusuke Tsuchimoto
Yoshiyuki Sawai
Takumi Igura
Hideko Ohama
Yuki Makino
Yasushi Matsumoto
Masanori Nakahara
Shin-ichirou Zushi
Yasuharu Imai
机构
[1] Department of Gastroenterology, Ikeda Municipal Hospital, Ikeda, Osaka 563-8510
关键词
Autoimmune hepatitis; Hepatocellular carcinoma; Overlap syndrome; Primary sclerosing cholangitis;
D O I
10.1007/s12328-012-0294-5
中图分类号
学科分类号
摘要
Development of hepatocellular carcinoma (HCC) in patients with autoimmune liver disease is less common than in those with other types of chronic liver disease. Here we report a rare case of overlap syndrome consisting of autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) that was subsequently complicated with HCC. A 72-year-old man was initially diagnosed as being in the cirrhotic stage of AIH on the basis of blood chemistry tests and histological examinations. Computed tomography and magnetic resonance cholangiography 20 months later showed diffuse stricturing of the intrahepatic bile duct with dilatation of the areas between the strictures, compatible with the findings of PSC, which resulted in a diagnosis of AIH/PSC overlap syndrome. The level of serum protein induced by vitamin K absence or antagonist II increased 22 months later, and HCC was diagnosed by radiological examinations. Four cycles of transarterial infusion therapy with cisplatin were performed, but the patient died one year later. Sequential overlap of PSC may have played a part in accelerating AIH disease progression, leading to the development of HCC in this patient. Therefore, HCC surveillance may be important in advanced stages of autoimmune disease, especially in the cirrhotic stage. © Springer 2012.
引用
收藏
页码:183 / 188
页数:5
相关论文
共 22 条
[1]  
Czala A.L., Manns M.P., Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis, Gastroenterology, 139, pp. 58-72, (2010)
[2]  
Chapman R., Fevery J., Kalloo A., Nagorney D.M., Boberg K.M., Shneider B., Et al., Diagnosis and management of primary sclerosing cholangitis, Hepatology, 51, pp. 660-678, (2010)
[3]  
Kaya M., Angulo P., Lindor K.D., Overlap of autoimmune hepatitis and primary sclerosing cholangitis: An evaluation of a modified scoring system, J Hepatol, 33, pp. 537-542, (2000)
[4]  
Floreani A., Rizzotto E.R., Ferrara F., Carderi I., Caroli D., Blasone L., Et al., Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome, Am J Gastroenterol, 100, pp. 1516-1522, (2005)
[5]  
Luth S., Kanzler S., Frenzel C., Kasper H.U., Dienes H.P., Schramm C., Et al., Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome, J Clin Gastroenterol, 43, pp. 75-80, (2009)
[6]  
Bruix J., Sherman M., AASLD practice guideline, Management of Hepatocellular Carcinoma: An Update. Hepatology, 3, pp. 1020-1022, (2011)
[7]  
Yeoman A.D., Al-Chalabi T., Karani J.B., Quaglia A., Devlin J., Mieli-Vergani G., Et al., Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening, Hepatology, 48, pp. 863-870, (2008)
[8]  
Wong R.J., Gish R., Frederick T., Bzoweji N., Frenette C., Development of hepatocellular carcinoma in autoimmune hepatitis patients: A case series, Dig Dis Sci, 56, pp. 578-585, (2011)
[9]  
Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.J., Et al., Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, pp. 169-176, (2008)
[10]  
Gregorio G.V., Portmann B., Karani J., Harrison P., Donaldson P.T., Vergani D., Et al., Autoimmune hepatitis/sclerosing overlap syndrome in childhood: A 16-year prospective study, Hepatology, 33, pp. 544-553, (2001)